Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3646
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02735369 | A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR | ||
| NCT03697161 | A Study of OV101 in Individuals With Fragile X Syndrome | ||
| NCT03109756 | Single Dose Pharmacokinetic (PK) Study | ||
| NCT04607772 | Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) | ||
| NCT00857662 | Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs) | ||
| NCT01460654 | Testosterone and Alendronate in Hypogonadal Men | ||
| NCT00378131 | Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia | ||
| NCT04313153 | Trial Evaluating the Efficacy and Safety of Oral Vadadustat Once Daily (QD) and Three Times Weekly (TIW) for the Maintenance Treatment of Anemia in Hemodialysis Subjects Converting From Erythropoiesis-Stimulating Agents (ESAs) | ||
| NCT01317927 | A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies | ||
| NCT06500273 | Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL | ||
| NCT03051256 | Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD | ||
| NCT06835569 | A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations | ||
| NCT02503137 | A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing | ||
| NCT02431429 | Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis | ||
| NCT05902988 | A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | ||
| NCT05071183 | A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors | ||
| NCT03272256 | Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma | ||
| NCT05708677 | A Long-Term Extension Study for Participants Previously Treated With EB-101 for the Treatment of RDEB | ||
| NCT00157534 | A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection | ||
| NCT07404111 | A Study of VV-14305 for the Treatment of Thyroid Eye Disease | ||
| NCT03054363 | Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer | ||
| NCT07027111 | Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDP | ||
| NCT03575598 | Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study | ||
| NCT05438147 | Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms | ||
| NCT03545438 | Study to Evaluate the Safety, PK, and Pharmacodynamics of LIB003 | ||
| NCT06747858 | Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis | ||
| NCT05814809 | Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers | ||
| NCT02189304 | Pharmacokinetics and Safety Study of PT010 in Healthy Subjects | ||
| NCT04249947 | P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) | ||
| NCT04565249 | Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 | ||
| NCT01607892 | Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer | ||
| NCT06467344 | Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) | ||
| NCT04880109 | A Phase 2 Study of APX-115 in Hospitalized Patients With Confirmed Mild to Moderate COVID-19. | ||
| NCT01751984 | A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance | ||
| NCT07220811 | Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy | ||
| NCT01505764 | The Role of Ghrelin in Cancer Cachexia | ||
| NCT05076552 | A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic Cancer | ||
| NCT01496118 | Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma | ||
| NCT06825559 | Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease | ||
| NCT07652697 | ABX-002 Bioequivalence and Effect of Food Study in Healthy Adult Participants | ||
| NCT06551623 | Drug-Drug Interactions Between TNP-2198 and Midazolam, Clarithromycin | ||
| NCT06437223 | Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC) | ||
| NCT05194046 | Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers | ||
| NCT03516760 | Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia | ||
| NCT06456424 | Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection | ||
| NCT07639723 | Aprepitant to Improve Same Day Discharge for TKA | ||
| NCT01494285 | Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients | ||
| NCT00406497 | Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation | ||
| NCT06616025 | This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations. | ||
| NCT05271591 | Generalizability of REDUCE-IT Results to People of South Asian Descent With Atherosclerotic Cardiovascular Disease in Canada (REDUCE-IT Canada SA) |
